コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 osocomial infections (p < 0.05, Mann-Whitney U test).
2 ers) in the MTX arm (P = .0435, Mann-Whitney U test).
3 ith undetectable VL (38.0 pg/mL) (P < .0001, U test).
4 atics than controls (p < 0.001, Mann-Whitney U test).
5 mained asymptomatic (P < 0.001, Mann-Whitney U test).
6 dural sinus stenosis [p=0.837], Mann-Whitney U test).
7 group (5 vs. 7 days; P < 0.001, Mann-Whitney U test).
8 3%, range -13-16%; P = 0.029 by Mann-Whitney U test).
9 laria (P, >0.1 for all enzymes; Mann-Whitney U test).
10 ed with the CMV group (p <.005; Mann-Whitney U test).
11 or absent p27 levels (P = 0.02, Mann-Whitney U test).
12 or 31 subjects without (P=0.02, Mann-Whitney U test).
13 ence medians 1.9-4.7, p<0.0001. Mann-Whitney U test).
14 (P = 0.0068, all Mann-Whitney nonparametric U test).
15 ntrols (8.2+/-1.3, n=5, P<0.02, Mann-Whitney U test).
16 n that in group 2 (P<0.05 using Mann-Whitney U test).
17 p130 (0.833 mg ml-1) (P < 0.05, Mann-Whitney U test).
18 spectively, p < .05 for both by Mann-Whitney U test).
19 234 + $12,146) costs (p < 0.01, Mann-Whitney U test).
20 n immunized animals (P = 0.014, Mann-Whitney U test).
21 nificant difference (P < 0.001, Mann-Whitney U test).
22 ps were significant (P = 0.001, Mann-Whitney U test).
23 18.5), respectively (P < 0.001; Mann-Whitney U test).
24 tion volumes by tumor location (Mann-Whitney U test).
25 % CI, 0.19-0.21 mg/L; P < .001; Mann-Whitney U test).
26 nts given the placebo (P = .02, Mann-Whitney U test).
27 n lesion tissue (all P < 0.005, Mann-Whitney U-test).
28 (0.9; 0.3-2.4 mU/l; P < 0.005, Mann-Whitney U-test).
29 23.14, respectively (P < 0.01, Mann-Whitney U-test).
30 QR 507-694) (-31.5%, P = 0.001, Mann-Whitney U-test).
31 kers was investigated using the Mann-Whitney U test.
32 in dose were assessed with the Mann-Whitney U test.
33 ompared between groups with the Mann-Whitney U test.
34 groups were compared by using a Mann-Whitney U test.
35 n correlation coefficient and a Mann-Whitney U test.
36 sitive control groups using the Mann-Whitney U test.
37 two-tailed Student's t-test or Mann-Whitney U test.
38 compared with Student t test or Mann-Whitney U test.
39 were compared with the Wilcoxon Mann-Whitney U test.
40 4 years were compared with the Mann-Whitney U test.
41 ancer and healthy groups by the Mann-Whitney U test.
42 ences were determined using the Mann-Whitney U test.
43 computed by using the t test or Mann-Whitney U test.
44 ta were tested statistically by Mann-Whitney U test.
45 e independent samples t test or Mann-Whitney U test.
46 ng groups were sought using the Mann-Whitney U test.
47 ic regression analyses, and the Mann-Whitney U test.
48 tatively and analyzed using the Mann-Whitney U test.
49 ric data were assessed with the Mann-Whitney U test.
50 nt plans were assessed with the Mann-Whitney U test.
51 stical analysis was by ANOVA or Mann Whitney U test.
52 with the independent t test or Mann-Whitney U test.
53 control mice with a two-tailed Mann-Whitney U test.
54 t and continuous variables with Mann-Whitney U test.
55 hose of normal subjects, by the Mann-Whitney U test.
56 e range) and compared using the Mann-Whitney U test.
57 of bone were compared using the Mann-Whitney U test.
58 motor seizures were done with a Mann-Whitney U test.
59 tests were conducted using the Mann-Whitney U test.
60 o CT were compared by using the Mann-Whitney U test.
61 ders and nonresponders with the Mann-Whitney U test.
62 (Pearson's coefficient) and the Mann-Whitney U test.
63 nding lesions were evaluated by Mann-Whitney U test.
64 ects were assessed by using the Mann-Whitney U test.
65 after RF ablation by using the Mann-Whitney U test.
66 nd continuous variables by the Mann--Whitney U test.
67 two-sample unpaired t test, and Mann-Whitney U test.
68 d with paired Student t test or Mann-Whitney U test.
69 n included the median, IQR, and Mann-Whitney U test.
70 ation, Pearson chi(2) test, and Mann-Whitney U test.
71 hips were assessed by using the Mann-Whitney U test.
72 fference was analyzed using the Mann-Whitney U test.
73 ith the Wilcoxon signed rank or Mann-Whitney U test.
74 d using Kruskal-Wallis test and Mann-Whitney U test.
75 sample t test and nonparametric Mann-Whitney U test.
76 strain ratio, analyzed with the Mann-Whitney U test.
77 Data were analyzed with the Mann-Whitney U test.
78 groups were compared by using a Mann-Whitney U test.
79 nchanging control genes using a Mann-Whitney U-test.
80 volumes were compared by use of Mann-Whitney U tests.
81 formed with the signed-rank and Mann-Whitney U tests.
82 ing multivariate analysis of variance, t, or U tests.
83 performed by Kruskal-Wallis and Mann-Whitney U tests.
84 e two groups were compared with Mann-Whitney U tests.
85 l questions were compared using Mann-Whitney U tests.
86 scimol during NMR conditioning and/or during US testing.
87 1) Kolmogorov-Smirnov test; 2) Mann-Whitney U test; 3) Pearson chi(2) test; 4) Kruskal-Wallis test;
90 I, was tested using a nonpaired Mann-Whitney U test, an analysis of covariance, and a Pearson chi2 te
98 ders were compared by using the Mann-Whitney U test and receiver operating characteristic analysis.
99 stical analysis was assessed by Mann-Whitney U test and Receiver operating characteristics (ROC) curv
101 Univariate analysis including Mann-Whitney U test and Spearman's correlation was conducted on selec
102 etric statistics, including the Mann-Whitney U test and the Kruskal-Wallis analysis of variance, were
107 ve value was investigated using Mann-Whitney U tests and receiver-operating-characteristic analysis.
109 between health and asthma using Mann-Whitney U tests and the Jonckheere-Terpstra test (linear trend a
110 Agreement was better between two Doppler US tests and between two contrast-enhanced MR angiograph
111 th increases of 66% (P = 0.004, Mann-Whitney U test) and 21% (P = 0.07) for patients who received pla
112 rative analysis between groups (Mann-Whitney U test) and a correlation analysis between glycemia and
113 (0.06 versus 0.34 mSv; P=0.037, Mann-Whitney U test) and lower median costs ($934 versus $1275; P=0.0
114 larger (68 vs. 34 mm2; P=0.08, Mann-Whitney U test) and were more likely to have papillomatous morph
115 uclear genomic cfDNA (p 10(-5), Mann-Whitney U Test), and an increased relative abundance of mitochon
116 cedural flow disruption scores (Mann-Whitney U test), and number of preventable failures (Fisher exac
121 tical analysis, Student t test, Mann-Whitney U test, and Spearman's correlation coefficient were used
122 e is typically analyzed using a Mann-Whitney U test, and the results are summarized by the mean of ra
127 is comprised paired t tests and Mann-Whitney U tests, as well as Pearson r and Spearman rho for corre
129 ignificant difference (P >0.05, Mann-Whitney U test) between the S or F inserts in the amount of cont
130 hat CRM was abolished by inactivation during US testing but intact following inactivation during NMR
132 was performed with the Wilcoxon Mann-Whitney U test, chi2 test, Wilcoxon matched-pairs signed-rank te
133 aired nontumorous tissues was performed on a US test cohort of 84 patients with incident colon adenoc
135 wise tests between tumor types (Mann-Whitney U test), (d) relationships between fast fluid-attenuated
137 E (p = 0.0002 vs control by the Mann-Whitney U test) enough to completely prevent fatal EAE, whereas
138 are paired samples, such as the Mann-Whitney U test (equivalent to the Wilcoxon rank sum test), the W
143 vs 30 min [5-90 min]; p<0.0001, Mann-Whitney U test); for each minute delay from onset of CSE to arri
146 significant reduction (P <0.05, Mann-Whitney U test) in the amount of contamination for both inserts
148 h QODD scores were tested using Mann-Whitney U tests, Kruskal-Wallis tests, or Spearman's rank-correl
149 ification.Data were analyzed by Mann-Whitney U-test, Kruskal-Wallis test and Cuzick's test followed b
150 s was significant (P = 0.005 on Mann-Whitney U test; mean ranks 13.9 and 6.3 [of 21], for juniors and
151 server agreement, McNemar test, Mann-Whitney U test, multiple regression analysis, Spearman correlati
152 tly higher median concentrations (p , 0.001, U test) of 8-OHdG in their mononuclear cells than their
153 oma (AC), whereas VB was lower (Mann-Whitney U test or t test, P = .003, P = .036, and P = .019, resp
155 ied out using Student's t-test, Mann-Whitney U test, or chi-square test (significance, p < .05).
159 us 73 +/- 24 nmol L(-1) d(-1) , Mann-Whitney U-test p < 0.0001), and the South Atlantic Bight (20 +/-
162 emonstrated construct validity (Mann-Whitney U test, P < 0.05), and learning curves for novices plate
166 wth in the upper tertile range (Mann-Whitney U test, p = 0.04) but not in the middle tertile (p = 0.9
179 is ANOVA-on-ranks with post hoc Mann-Whitney U tests showed significant pairwise between-cluster diff
180 (ANOVA)-on-Ranks with post-hoc Mann-Whitney U-tests showed significant pairwise between-cluster diff
181 egression analysis; P =.25-.75, Mann-Whitney U test; Spearman correlation coefficients between -0.33
182 desaturase is active as a homodimer prompted us test the hypothesis that an archetypal integral membr
194 used for significance, and the Mann-Whitney U test was used for pairwise comparison of the groups.
202 unctional development, Wilcoxon-Mann-Whitney U test was used to compare the medians of 2 groups and K
204 asticatory performance, and the Mann-Whitney U test was used to determine quality of life (P <0.05).
207 e not normally distributed, the Mann-Whitney U-test was employed to assess the statistical validity o
212 nt t, chi(2), Fisher exact, and Mann-Whitney U tests were applied to analyze the differences between
217 is performed by an extension of Mann-Whitney U test which is based on weighted rank sums computed fro
223 differentiated VCD vs. healthy (Mann-Whitney U-test: z = -5.390, P < 0.001) and asthma (z = -5.730, P
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。